Roberto M. H.
- Country
- Spain
- Department
- Department of oncology
Research Overview
- Phase I Study of OKI-219 Monotherapy and in Combination with Endocrine or HER2-Targeted Therapy in Advanced Solid Tumors and Breast Cancer
- Phase 1 Evaluation of NDI-219216 in Advanced Solid Tumors with/without Microsatellite Instability and Deficient Mismatch Repair
- Phase II Trial of DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Data & Insights
Has run more than one trial at 19 of 80 partner sites.
Specializations
Oncology Research
This investigator specializes in studying advanced solid tumors, contributing to the development of novel therapeutic approaches in clinical oncology.
- Solid Tumor Treatment
- Cancer Therapeutics
- Advanced Stage Cancer Care
Their research activities focus on evaluating innovative treatment modalities for patients with progressive solid tumors.
Therapeutic Development
The investigator's work encompasses the evaluation of experimental therapeutics for treating advanced-stage cancers.
- Drug Development
- Treatment Innovation
- Clinical Applications
Their expertise extends to investigating new therapeutic compounds for oncology applications.
Clinical Assessment
Specializing in early-phase clinical evaluation of emerging cancer treatments.
- Patient Safety Assessment
- Treatment Efficacy
- Clinical Outcomes
The investigator focuses on determining the clinical potential of new therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.